Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.93 |
| ▸ | FDPS | P14324 | 15/20 | 0.47 |
| ▸ | PGK1 | P00558 | 1/20 | 0.45 |
| ▸ | PGK2 | P07205 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Etidronic Acid SCHEMBL10532992 | 0.96 | LMNA (1.00) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL18607 | 0.96 | LMNA (1.00) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL3130855 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL10524952 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL636757 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL10706705 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL1924063 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL6141145 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL3896726 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL17580248 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106456662-A | Compositions of pentosan polysulfate for oral administration and methods of use thereof | 奥利金制药公司 | 2017-02-22 | — | — | CN | claimed |
| EP-2416756-A2 | STABLE PHARMACEUTICAL COMPOSITIONS WITH HIGH BIOAVAILIBILITY | Bilgic, Mahmut (TR) | 2012-02-15 | — | — | EP | claimed |
| WO-2010117346-A2 | STABLE PHARMACEUTICAL COMPOSITIONS WITH HIGH BIOAVAILIBILITY | BILGIC MAHMUT (TR) | 2010-10-14 | — | — | WO | claimed |
| CN-106456662-A | Compositions of pentosan polysulfate for oral administration and methods of use thereof | 奥利金制药公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-101139361-B | Targeted anti-osteoporosis medicine and preparation method thereof | WESTERN CHINA HOSPITAL SCU | 2012-03-28 | — | — | CN | disclosed |
| EP-2416756-A2 | STABLE PHARMACEUTICAL COMPOSITIONS WITH HIGH BIOAVAILIBILITY | Bilgic, Mahmut (TR) | 2012-02-15 | — | — | EP | disclosed |
| WO-2010117346-A2 | STABLE PHARMACEUTICAL COMPOSITIONS WITH HIGH BIOAVAILIBILITY | BILGIC MAHMUT (TR) | 2010-10-14 | — | — | WO | disclosed |
| CN-101139361-A | Targeted anti-osteoporosis medicine and preparation method thereof | WEST CHINA HOSPITAL SICHUAN UNIV (CN) | 2008-03-12 | — | — | CN | disclosed |